Table of Contents Table of Contents
Previous Page  870 / 1631 Next Page
Information
Show Menu
Previous Page 870 / 1631 Next Page
Page Background

Young (age 18-59) aa IPI 1

n=380

Median age 47

55% stage III/IV, 44% bulk

Other ways of improving dose intensity:

GELA LNH03-2B

Recher C

, et al Lancet

2011: 378:1858-18676.